Funding for this research was provided by:
CAPES
Article History
Received: 27 September 2023
Accepted: 23 April 2024
First Online: 3 May 2024
Declarations
:
: This study was approved by the Ethics Committee of the University of Campinas in December 2021 and followed the tenets of the Declaration of Helsinki.All procedures are fully explained to the participants and an informed consent is obtained at inclusion.This study was retrospectively registered at the Registro Brasileiro de Ensaios Clínicos (ReBEC) platform, number RBR-268ms5y (registration date: July 29, 2023).
: Not applicable — no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results.
: GA: Ofta — speaker.TDF: Abbvie — consultant, speaker; Elios — consultant; Iantrek — consultant; Nova Eye Medical — consultant; Glaukos — consultant; Myra Vision — consultant; Vialase — consultant; Zeiss — consultant.VPC: Alcon — speaker; Allergan-Abbvie — consultant, speaker, Grants; Iridex — speaker; Zeiss — consultant, speaker, grants.